Edition:
United States

Eiger BioPharmaceuticals Inc (EIGR.OQ)

EIGR.OQ on NASDAQ Stock Exchange Global Market

11.85USD
17 Aug 2018
Change (% chg)

$0.05 (+0.42%)
Prev Close
$11.80
Open
$11.60
Day's High
$11.85
Day's Low
$11.45
Volume
19,199
Avg. Vol
38,428
52-wk High
$18.00
52-wk Low
$7.50

Select another date:

Wed, May 23 2018

BRIEF-Eiger Biopharmaceuticals Announces Proposed Public Offering Of Common Stock

* EIGER BIOPHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

BRIEF-Progeria Research Foundation Announces Collaboration, Supply Agreement With Eiger Biopharma

* PROGERIA RESEARCH FOUNDATION ANNOUNCES COLLABORATION AND SUPPLY AGREEMENT WITH EIGER BIOPHARMACEUTICALS Source text for Eikon: Further company coverage:

BRIEF-Eiger Announces Expanded License Agreement With Merck For Lonafarnib

* EIGER ANNOUNCES EXPANDED LICENSE AGREEMENT WITH MERCK FOR INVESTIGATIONAL CANDIDATE LONAFARNIB AND COLLABORATION WITH THE PROGERIA RESEARCH FOUNDATION (PRF) Source text for Eikon: Further company coverage:

BRIEF-Eiger Biopharmaceuticals Reports First Quarter 2018 Financial Results

* EIGER BIOPHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Eiger Biopharmaceuticals Sees Phase 3 D-Livr Trial Starting In Second Half 2018​

* EIGER BIOPHARMACEUTICALS ANNOUNCES POSITIVE GUIDANCE FOLLOWING FDA MEETING ON HEPATITIS DELTA VIRUS REGISTRATION PROGRAM

BRIEF-Eiger Biopharmaceuticals Q4 Loss Per Share $1.11

* EIGER BIOPHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Select another date: